EAACI guidelines: Anaphylaxis (2021 update)
- PMID: 34343358
- DOI: 10.1111/all.15032
EAACI guidelines: Anaphylaxis (2021 update)
Abstract
Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to recognize and manage. The European Academy of Allergy and Clinical Immunology Anaphylaxis multidisciplinary Task Force has updated the 2014 guideline. The guideline was developed using the AGREE II framework and the GRADE approach. The evidence was systematically reviewed and recommendations were created by weighing up benefits and harms. The guideline was peer-reviewed by external experts and reviewed in a public consultation. The use of clinical criteria to identify anaphylaxis is suggested with blood sampling for the later measurement of tryptase. The prompt use of intramuscular adrenaline as first-line management is recommended with the availability of adrenaline autoinjectors to patients in the community. Pharmacokinetic data should be provided for adrenaline autoinjector devices. Structured, comprehensive training for people at risk of anaphylaxis is recommended. Simulation training and visual prompts for healthcare professionals are suggested to improve the management of anaphylaxis. It is suggested that school policies reflect anaphylaxis guidelines. The evidence for the management of anaphylaxis remains mostly at a very low level. There is an urgent need to prioritize clinical trials with the potential to improve the management of patients at risk of anaphylaxis.
Keywords: adults; anaphylaxis; children; guidelines.
© 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Comment in
-
Comment on EAACI guideline: Anaphylaxis (2021 update).Allergy. 2022 Jul;77(7):2268. doi: 10.1111/all.15256. Allergy. 2022. PMID: 35770816 No abstract available.
Similar articles
-
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.Allergy. 2014 Aug;69(8):1026-45. doi: 10.1111/all.12437. Epub 2014 Jun 9. Allergy. 2014. PMID: 24909803
-
EAACI Task force Clinical epidemiology of anaphylaxis: experts' perspective on the use of adrenaline autoinjectors in Europe.Clin Transl Allergy. 2020 May 11;10:12. doi: 10.1186/s13601-020-00317-y. eCollection 2020. Clin Transl Allergy. 2020. PMID: 32426107 Free PMC article.
-
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update).Pediatr Allergy Immunol. 2021 Jul;32(5):843-858. doi: 10.1111/pai.13496. Epub 2021 Mar 29. Pediatr Allergy Immunol. 2021. PMID: 33710678
-
Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes.J Allergy Clin Immunol Pract. 2023 Apr;11(4):1036-1046. doi: 10.1016/j.jaip.2023.02.002. Epub 2023 Feb 14. J Allergy Clin Immunol Pract. 2023. PMID: 36796511 Free PMC article. Review.
-
Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years).J Allergy Clin Immunol. 2015 May;135(5):1125-31. doi: 10.1016/j.jaci.2014.09.014. Epub 2014 Oct 30. J Allergy Clin Immunol. 2015. PMID: 25441636 Review.
Cited by
-
Fatal food anaphylaxis in adults and children.Ital J Pediatr. 2024 Mar 5;50(1):40. doi: 10.1186/s13052-024-01608-x. Ital J Pediatr. 2024. PMID: 38439086 Free PMC article. Review.
-
A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector.J Allergy Clin Immunol Glob. 2023 Dec 12;3(2):100200. doi: 10.1016/j.jacig.2023.100200. eCollection 2024 May. J Allergy Clin Immunol Glob. 2023. PMID: 38328805 Free PMC article.
-
Anaphylactic Shock After Cervical Conization Hemostasis With a Packing Soaked in Monsel's Solution.Cureus. 2024 Jan 3;16(1):e51603. doi: 10.7759/cureus.51603. eCollection 2024 Jan. Cureus. 2024. PMID: 38313957 Free PMC article.
-
Perspectives and gaps in the management of food allergy and anaphylaxis in the Asia-Pacific Region.J Allergy Clin Immunol Glob. 2023 Dec 23;3(2):100202. doi: 10.1016/j.jacig.2023.100202. eCollection 2024 May. J Allergy Clin Immunol Glob. 2023. PMID: 38283085 Free PMC article.
-
Tirzepatide-Induced Biphasic Anaphylactic Reaction: A Case Report.Cureus. 2023 Dec 7;15(12):e50112. doi: 10.7759/cureus.50112. eCollection 2023 Dec. Cureus. 2023. PMID: 38186543 Free PMC article.
References
REFERENCES
-
- Simons FE, Ardusso LR, Bilo MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9.
-
- Bilo MB, Corsi A, Martini M, Penza E, Grippo F, Bignardi D. Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004-2016. Allergy. 2020;75(10):2644-2652.
-
- Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015;135(4):956-963.e1.
-
- Greenhawt M, Gupta RS, Meadows JA, et al. Guiding principles for the recognition, diagnosis, and management of infants with anaphylaxis: an expert panel consensus. J Allergy Clin Immunol Pract 2019;7(4):1148-1156 e1145.
-
- Francuzik W, Ruëff F, Bauer A, et al. Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry. J Allergy Clin Immunol. 2021;147(2):653-662.e9. https://doi.org/10.1016/j.jaci.2020.06.008. Epub 2020 Jun 22.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
